Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac premedication for IANB in irreversible pulpitis
NCT02940405Unknown
- Sponsor
- Cairo University
- Start
- Jan 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in irreversible pulpitis comparing Ketorolac Tromethamine with Placebo (2 arms). Primary endpoint: Anesthetic efficiency. Status: unknown.
02
Drugs
ketorolac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT02940405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02940405.